Arvid Sjölander

Featured in: Favicon

nature.com Favicon

biomedcentral.com Favicon

jamanetwork.com Favicon

medscape.com Favicon

thelancet.com Favicon

aacrjournals.org Favicon

onlinelibrary.wiley.com Favicon

gut.bmj.com + 2 more

Articles

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study

Jun 20, 2024 | thelancet.com | Bowen Tang |Arvid Sjölander |Jonas W. Wastesson

9Hernán M.A. Robins J.M. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 183: 758-764 The trial emulation is specified in We used the framework proposed by Hernán and Robins to simulate a three-arm RCT comparing the dementia risk among GLP-1 agonist, DPP-4 inhibitor, and sulfonylurea initiators.Table 1.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →